Marianne Helenius

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Machine Learning

Prognostic Factors

Ejection Fraction

Cross Sectional

Top Venues

Nature communications

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Rikke Linnemann Nielsen, Thomas Monfeuga, Robert R Kitchen, Line Egerod, Luis G Leal, August Thomas Hjortshøj Schreyer, Frederik Steensgaard Gade, Carol Sun, Marianne Helenius, Lotte Simonsen, Marianne Willert, Abd A Tahrani, Zahra McVey, Ramneek Gupta
Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nature communications 15 (1) (2024)
Rikke Linnemann Nielsen, Thomas Monfeuga, Robert R Kitchen, Line Egerod, Luis G Leal, August Thomas Hjortshøj Schreyer, Frederik Steensgaard Gade, Carol Sun, Marianne Helenius, Lotte Simonsen, Marianne Willert, Abd A Tahrani, Zahra McVey, Ramneek Gupta
Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nature communications 15 (1) (2024)
Rikke Linnemann Nielsen, Thomas Monfeuga, Robert R Kitchen, Line Egerod, Luis G Leal, August Thomas Hjortshøj Schreyer, Frederik Steensgaard Gade, Carol Sun, Marianne Helenius, Lotte Simonsen, Marianne Willert, Abd A Tahrani, Zahra McVey, Ramneek Gupta
Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nature communications 15 (1) (2024)
Marianne Helenius, Goda Vaitkeviciene, Jonas Abrahamsson, Ólafur Gisli Jonsson, Bendik Lund, Arja H Harila-Saari, Kim Vettenranta, Sirje Mikkel, Martin Stanulla, Elixabet Lopez-Lopez, Esmé Waanders, Hans O Madsen, Hanne Vibeke Marquart, Signe Modvig, Ramneek Gupta, Kjeld Schmiegelow, Rikke Linnemann Nielsen
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype study. Pediatric blood & cancer 69 (6) (2022)